A citation-based method for searching scientific literature

D Osoba, G Rodrigues, J Myles, B Zee, J Pater. J Clin Oncol 1998
Times Cited: 1897







List of co-cited articles
287 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
N K Aaronson, S Ahmedzai, B Bergman, M Bullinger, A Cull, N J Duez, A Filiberti, H Flechtner, S B Fleishman, J C de Haes. J Natl Cancer Inst 1993
58


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
14


New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
9


Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.
Johannes M Giesinger, Jacobien M Kieffer, Peter M Fayers, Mogens Groenvold, Morten Aa Petersen, Neil W Scott, Mirjam A G Sprangers, Galina Velikova, Neil K Aaronson. J Clin Epidemiol 2016
163
8


The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
7

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.
A Simon Pickard, Maureen P Neary, David Cella. Health Qual Life Outcomes 2007
463
6

A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.
K Bjordal, A de Graeff, P M Fayers, E Hammerlid, C van Pottelsberghe, D Curran, M Ahlner-Elmqvist, E J Maher, J W Meyza, A Brédart,[...]. Eur J Cancer 2000
471
5

General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
S Nolte, G Liegl, M A Petersen, N K Aaronson, A Costantini, P M Fayers, M Groenvold, B Holzner, C D Johnson, G Kemmler,[...]. Eur J Cancer 2019
108
5

A point of minimal important difference (MID): a critique of terminology and methods.
Madeleine T King. Expert Rev Pharmacoecon Outcomes Res 2011
310
5

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Martin J B Taphoorn, Lily Claassens, Neil K Aaronson, Corneel Coens, Murielle Mauer, David Osoba, Roger Stupp, René O Mirimanoff, Martin J van den Bent, Andrew Bottomley. Eur J Cancer 2010
194
5

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Julie R Brahmer, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. Lancet Oncol 2017
147
4

Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?
Amélie Anota, Zeinab Hamidou, Sophie Paget-Bailly, Benoist Chibaudel, Caroline Bascoul-Mollevi, Pascal Auquier, Virginie Westeel, Frederic Fiteni, Christophe Borg, Franck Bonnetain. Qual Life Res 2015
58
6

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.
David J Vaughn, Joaquim Bellmunt, Yves Fradet, Jae Lyun Lee, Lawrence Fong, Nicholas J Vogelzang, Miguel A Climent, Daniel P Petrylak, Toni K Choueiri, Andrea Necchi,[...]. J Clin Oncol 2018
51
7

Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population.
Amanda Purcell, Jennifer Fleming, Sally Bennett, Bryan Burmeister, Terry Haines. Support Care Cancer 2010
47
8

Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research.
Johannes M Giesinger, Fanny L C Loth, Neil K Aaronson, Juan I Arraras, Giovanni Caocci, Fabio Efficace, Mogens Groenvold, Marieke van Leeuwen, Morten Aa Petersen, John Ramage,[...]. J Clin Epidemiol 2020
42
9

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.
Ethan Basch, Allison M Deal, Amylou C Dueck, Howard I Scher, Mark G Kris, Clifford Hudis, Deborah Schrag. JAMA 2017
721
4

Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable.
Kristin L Campbell, Kerri M Winters-Stone, Joachim Wiskemann, Anne M May, Anna L Schwartz, Kerry S Courneya, David S Zucker, Charles E Matthews, Jennifer A Ligibel, Lynn H Gerber,[...]. Med Sci Sports Exerc 2019
335
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
4


Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma.
Martin J B Taphoorn, Roger Henriksson, Andrew Bottomley, Timothy Cloughesy, Wolfgang Wick, Warren P Mason, Frank Saran, Ryo Nishikawa, Magalie Hilton, Christina Theodore-Oklota,[...]. J Clin Oncol 2015
81
4


The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.
M A Sprangers, M Groenvold, J I Arraras, J Franklin, A te Velde, M Muller, L Franzini, A Williams, H C de Haes, P Hopwood,[...]. J Clin Oncol 1996
678
4

Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma.
Dirk Schadendorf, Reinhard Dummer, Axel Hauschild, Caroline Robert, Omid Hamid, Adil Daud, Alfons van den Eertwegh, Lee Cranmer, Steven O'Day, Igor Puzanov,[...]. Eur J Cancer 2016
46
6

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
3


Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review.
Youssef Ben Bouazza, Ibrahim Chiairi, Ouiam El Kharbouchi, Lesley De Backer, Greetje Vanhoutte, Annelies Janssens, Jan P Van Meerbeeck. Lung Cancer 2017
43
6

Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
Pernilla Lagergren, Peter Fayers, Thierry Conroy, Hubert J Stein, Orhan Sezer, Richard Hardwick, Eva Hammerlid, Andrew Bottomley, Eric Van Cutsem, Jane M Blazeby. Eur J Cancer 2007
94
3

Health-related quality of life among patients cured by surgery for esophageal cancer.
Pernilla Lagergren, Kerry N L Avery, Rachael Hughes, C Paul Barham, Derek Alderson, Stephen J Falk, Jane M Blazeby. Cancer 2007
135
3


Novel Methods for Reporting of Exercise Dose and Adherence: An Exploratory Analysis.
Tormod S Nilsen, Jessica M Scott, Meghan Michalski, Catherine Capaci, Samantha Thomas, James E Herndon, John Sasso, Neil D Eves, Lee W Jones. Med Sci Sports Exerc 2018
31
9

Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A Randomized Clinical Trial.
Enrico M Minnella, Rashami Awasthi, Sarah-Eve Loiselle, Ramanakumar V Agnihotram, Lorenzo E Ferri, Francesco Carli. JAMA Surg 2018
99
3

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Chantal Quinten, Corneel Coens, Murielle Mauer, Sylvie Comte, Mirjam A G Sprangers, Charles Cleeland, David Osoba, Kristin Bjordal, Andrew Bottomley. Lancet Oncol 2009
358
3

The prognostic significance of patient-reported outcomes in cancer clinical trials.
Carolyn C Gotay, Crissy T Kawamoto, Andrew Bottomley, Fabio Efficace. J Clin Oncol 2008
387
3

Early palliative care for patients with metastatic non-small-cell lung cancer.
Jennifer S Temel, Joseph A Greer, Alona Muzikansky, Emily R Gallagher, Sonal Admane, Vicki A Jackson, Constance M Dahlin, Craig D Blinderman, Juliet Jacobsen, William F Pirl,[...]. N Engl J Med 2010
3

Human papillomavirus and survival of patients with oropharyngeal cancer.
K Kian Ang, Jonathan Harris, Richard Wheeler, Randal Weber, David I Rosenthal, Phuc Felix Nguyen-Tân, William H Westra, Christine H Chung, Richard C Jordan, Charles Lu,[...]. N Engl J Med 2010
3

The Exercise and Sports Science Australia position statement: Exercise medicine in cancer management.
Sandra C Hayes, Robert U Newton, Rosalind R Spence, Daniel A Galvão. J Sci Med Sport 2019
92
3


Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2018
3

Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer.
Norbert Marschner, Stefan Zacharias, Florian Lordick, Susanna Hegewisch-Becker, Uwe Martens, Anja Welt, Volker Hagen, Wolfgang Gleiber, Sabine Bohnet, Lisa Kruggel,[...]. JAMA Netw Open 2020
10
30

Quality of life in oral carcinoma: a 5-year prospective study.
Mats Nordgren, Eva Hammerlid, Kristin Bjordal, Marianne Ahlner-Elmqvist, Morten Boysen, Magnus Jannert. Head Neck 2008
63
4


Psychological distress in patients with pancreatic cancer--an understudied group.
Karen L Clark, Matthew Loscalzo, Peter C Trask, James Zabora, Errol J Philip. Psychooncology 2010
67
4


Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.
Erin Wong, Liying Zhang, Marc Kerba, Palmira Foro Arnalot, Brita Danielson, May Tsao, Gillian Bedard, Nemica Thavarajah, Paul Cheon, Cyril Danjoux,[...]. Support Care Cancer 2015
11
27

Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol.
Zebedee Jammbe Musoro, Jean-Francois Hamel, Divine Ewane Ediebah, Kim Cocks, Madeleine T King, Mogens Groenvold, Mirjam A G Sprangers, Yvonne Brandberg, Galina Velikova, John Maringwa,[...]. BMJ Open 2018
26
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.